March 28, 2020
Diabetic Footwear

Diabetic Footwear Market 2025 | Top Leading players are Aetrex Worldwide, Orthotic Holdings, Apis Footwears and many more

The global market for diabetic footwear was valued at US$ 4,971.25 million in 2016 and is expected to reach US$ 9,495.01 million each by 2025, increasing to CAGR by 8.0 per cent from 2017 to 2025.

Diabetic shoes, also referred to as therapeutic shoes, are shoes specially designed for diabetic patients to reduce the risk of diabetic skin breakdown along with co-existing foot disease. The global market for diabetic shoes is driven mainly by the increasing prevalence of diabetes (21-75 years of age) worldwide. Among consumers, these shoes have received fair acceptance as their level of comfort is optimized compared to normal shoes.

Credence Research is Providing Premium Sample of This Report:

Apart from the increasing prevalence of diabetes, the increase in expenditure on diabetes treatment is another factor driving market growth. Global expenditure on diabetes in 2015 was more than USD 650 billion and is projected to exceed USD 800 billion by 2024. Increased geriatric population, often suffering from diabetic conditions, is another major factor in increasing demand.

Sandals is expected to experience a CAGR of 7.4 per cent between 2019 and 2025, due to the increased use of these products as casual footwear by people aged 45+ in developed economies, including Germany and the United Kingdom. In 2018, Slippers generated revenue of USD 1.99 billion. The segment is supposed to hold more than 31% of the global market share as a result of the predominant use of daily home footwear among health-conscious consumers. Over the next eight years, the online segment is supposed to remain the most lucrative distribution channel. These channels are supposed to remain the preferred choice on the basis of various value-added benefits, including cash benefits and the free-home delivery of footwear companies and e-commerce portals. It is anticipated that Europe will remain one of the largest markets, accounting for more than USD 1.93 billion by 2025. The region is supposed to lead by increasing consumer health awareness from prominent markets such as Germany, the United Kingdom, France and Italy.The market for diabetic footwear is highly competitive in nature with key players, including DJO Global Inc.; Drew Shoes; I-Runner; and Dr. Zen Products, Inc. Different manufacturers focus on new product launches, expansion of capacity and technological innovation to meet existing and future demand from new application segments.

Based on geography, Asia-Pacific has a market share of 36.8 per cent of the global market for diabetic footwear in 2016. The increase in population aging in major economies, such as China, Japan and others, with their rising disposable income, has a high demand in the Asia-Pacific region.On the other hand, North America also holds the largest market share of 29.7 percent in 2016 on the global diabetic footwear market due to the vast population of diabetic patients and the awareness of the benefits of diabetic footwear among the diabetic population.

Credence Research is Providing Premium Sample of This Report:

Leave a Reply

Your email address will not be published. Required fields are marked *